Mohamed Ibrahim

Mohamed Ibrahim is a Postdoctoral Research Associate at the Nuffield Department of Clinical Neurosciences (NDCN), University of Oxford, actively contributing to the Cerebellar Disease Group. His work bridges molecular neuroscience and clinical neurology through advanced mouse model research.

His research centers on cerebellar pathophysiology in neurodegenerative disorders, with emphasis on motor dysfunction mechanisms in spinocerebellar ataxia, essential tremor, and Alzheimer's disease. Using electrophysiological techniques and behavioral analyses, he investigates Purkinje cell dysfunction, synaptic transmission abnormalities, and region-specific cerebellar vulnerabilities. His approach integrates genetic models with therapeutic intervention studies to uncover disease progression pathways.

Publication analysis reveals a strong trajectory in cerebellar neurobiology: recent work (2021-2025) examines mGluR1 signaling in motor deficits and essential tremor pathogenesis, while earlier studies (2017) demonstrated that early intervention in SCA1 models prevents architectural degeneration. This consistent focus on cerebellar circuitry dysfunction highlights translational potential for movement disorder treatments.

No scientific awards are documented in available sources.

Current information indicates no formal student supervision roles or grant leadership. His research is conducted within Oxford's collaborative neuroscience infrastructure.

As a core member of the Cerebellar Disease Group, Ibrahim contributes to Oxford's internationally recognized research on cerebellar function, utilizing transgenic models and multidisciplinary approaches to address fundamental questions in motor control pathology.